American Society of Hematology, 56th Annual Meeting & Exposition: Advisors’ Introduction.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. ii, doi. 10.1177/1559897715571306
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2014 AND VI 14 AND IP 55
Results: 26
1
2
Noninvasive Detection of Genomic Imbalances in HL Is Promising.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 18, doi. 10.1177/1559897715570844
- By:
- Publication type:
- Article
3
Vosaroxin in Combination With Cytarabine Provides a New Salvage Option for AML.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 15, doi. 10.1177/1559897715570843
- By:
- Publication type:
- Article
4
Sorafenib as Effective Treatment for Newly Diagnosed AML in Younger Patients.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 8, doi. 10.1177/1559897715570842
- By:
- Publication type:
- Article
5
ASCT for Multiple Myeloma: The Role of the Novel Agents.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 31, doi. 10.1177/1559897715570841
- By:
- Publication type:
- Article
6
Coagulation Therapy and Thrombosis.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 23, doi. 10.1177/1559897715570840
- By:
- Publication type:
- Article
7
Advances and Challenges in Sickle Cell Anemia.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 2, doi. 10.1177/1559897715570839
- By:
- Publication type:
- Article
8
MRD and Clinical Response Predictors of PFS in CLL.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 17, doi. 10.1177/1559897715570607
- By:
- Publication type:
- Article
9
4F-PCC Reverses Apixaban Anticoagulation in Healthy Volunteers.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 21, doi. 10.1177/1559897715570602
- By:
- Publication type:
- Article
10
Reduced-Dose Conditioning Comparable to Standard Dose Prior to ASCT in MDS.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 20, doi. 10.1177/1559897715570601
- By:
- Publication type:
- Article
11
Tinzaparin Reduces the Risk of Recurrent Thromboembolic Events in Patients With Cancer.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 12, doi. 10.1177/1559897714568645
- By:
- Publication type:
- Article
12
JAK2-STAT3 Signaling Implicated in the Regulation of Hepatic TPO Production.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 4, doi. 10.1177/1559897715570609
- By:
- Publication type:
- Article
13
FXI-ASO May Represent a New Class of Antithrombotic Agents.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 10, doi. 10.1177/1559897714568644
- By:
- Publication type:
- Article
14
AALL0434 Treatment Therapy Has Excellent Outcomes in Children With T-ALL.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 5, doi. 10.1177/1559897715570608
- By:
- Publication type:
- Article
15
FCR Superior in Treatment of Advanced CLL.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 16, doi. 10.1177/1559897715570605
- By:
- Publication type:
- Article
16
CKT Implicated in Worse Outcomes With Ibrutinib Therapy of CLL.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 16, doi. 10.1177/1559897715570606
- By:
- Publication type:
- Article
17
Dasatinib Outcomes Maintained Over 5 Years.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 19, doi. 10.1177/1559897715570603
- By:
- Publication type:
- Article
18
PCC Reverses Dabigatran-Associated Bleeding in Polytrauma Model.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 22, doi. 10.1177/1559897715570604
- By:
- Publication type:
- Article
19
Treatment Paradigms for MPNs Continue to Evolve.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 28, doi. 10.1177/1559897714568643
- By:
- Publication type:
- Article
20
Activity of Lenalidomide in MDS Tied to Degradation of CSNK1A1.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 7, doi. 10.1177/1559897714568636
- By:
- Publication type:
- Article
21
Th17-Prone CD146+CCR5+ T-Cell Population Is an Early Marker of Intestinal GVHD.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 8, doi. 10.1177/1559897714568635
- By:
- Publication type:
- Article
22
Insights Into Pathophysiology of Lymphomas Help Identify Therapeutic Targets.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 26, doi. 10.1177/1559897714568634
- By:
- Publication type:
- Article
23
Idarucizumab Reverses Dabigatran in Elderly or Renally Impaired.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 14, doi. 10.1177/1559897714568633
- By:
- Publication type:
- Article
24
Benefit of Extended Anticoagulation After Unprovoked PE Lost After Treatment Discontinuation.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 11, doi. 10.1177/1559897714568629
- By:
- Publication type:
- Article
25
Clonal Mapping of Hematopoiesis In Vivo Provides Direction for New Clinical Protocols.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 6, doi. 10.1177/1559897714568628
- By:
- Publication type:
- Article
26
AZA Plus LEN or VOR Do Not Improve Response Rates in MDS or CMML, Though DFS and OS Still an Open Question.
- Published in:
- MD Conference Express, 2014, v. 14, n. 55, p. 13, doi. 10.1177/1559897714568624
- By:
- Publication type:
- Article